Clinician Responsible for Training and Review: Emergency Department Consultant

Similar documents
Clinician Responsible for Training and Review: Emergency Department Consultant

Patient Group Direction for the supply and/or administration of Ibuprofen 400mg tablets to patients attending NHS Borders services

SAMPLE. PGD Reviewed by: Chris Faldon, John Maloney, Tim Patterson, Adrian MacKenzie, Claire Stein

Continence PGD transdermal oxybutynin Kentera patch 36mg

SAMPLE. This direction was authorised on 4/5/2007. The direction will be reviewed by 4/5/2009

SAMPLE. PGD reviewed by: Dr Tim Patterson, Chris Faldon, John Maloney, Adrian Mackenzie

Document Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml

Document Details Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No Local Ref (optional) Main points the

Document Details. Patient Group Direction

Author of PGD: Adrian MacKenzie, Lead Pharmacist, Primary and Community Care.

Document Details. Patient Group Direction

Expiry Date: September 2009 Template Version: Page 1 of 7

This document expires on Patient Group Direction No. VI 11

This document expires on Patient Group Direction No. VI 5

GG&C PGD ref no: 2016/1338 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

This document expires on Patient Group Direction Number VI 19

This document expires on Patient Group Direction No. VI 7

GG&C PGD ref no: 2016/1408 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

GG&C PGD ref no: 2017/1427 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

PATIENT GROUP DIRECTION. Oral (live attenuated) Typhoid Vaccine (Ty21a) (Vivotif )

Developed By Name Signature Date

Administration of Tuberculin Purified Protein Derivative (PPD) 2TU per 0.1ml to patients attending BCG clinics with identified TB at risk factors.

Clinical Condition Indication:

Clinical Condition Indication:

HEPATITIS A + TYPHOID VACCINE

PATIENT GROUP DIRECTION (PGD)

Community Psychiatric Nurse. Consultant Psychiatrist, Substance Misuse Services

GG&C PGD ref no: 2018/1603 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

Borders. Patient Group Direction (PGD) Development Policy For NHS Borders

Patient Group Direction No. VI 17. Kathy Wakefield/Lisa Murray. General Practices & TRFT. Relevant Clinical Lead

Administration of Hepatitis A and B Vaccine

GG&C PGD ref no: 2018/1589 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

PATIENT GROUP DIRECTION PROCEDURE

Prescription only medicines (POMs)

Expiry Date: July 2009 Template Version: Page 1 of 7

PATIENT GROUP DIRECTION (PGD) Supply of potassium iodide 65mg tablets to adults and children exposed to, or at risk of exposure to radioactive iodine

PATIENT GROUP DIRECTION

by registered nurses employed by NHS Hertfordshire or Hertfordshire GP Practices and signatories to the PGD

Developed By Name Signature Date

PATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OF DOXYCYCLINE 100MG TABLETS FOR THE FIRST-LINE TREATMENT OF CHLAMYDIA TRACHOMATIS INFECTION

Patient Group Direction for Measles, Mumps & Rubella Vaccine. PGD Version No.: 7/2013.

Continence PGD - Oxybutynin 5mg Modified Release

patient group direction

PATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OR ADMINISTRATION OF LEVONORGESTREL 1500 MICROGRAM TABLET (e.g LEVONELLE 1500 ) PGD

Patient Group Direction For the supply and administration of

patient group direction

Patient Group Direction for the Supply of Nitrofurantoin MR 100mg capsules

PGD No Administration of Human Papillomavirus Vaccine (HPV) Types 6, 11, 16 and 18 - Gardasil - September 2012

CALDERDALE PRIMARY CARE TRUST

Patient Group Direction For the supply and administration of

PATIENT GROUP DIRECTIONS POLICY

NHS Lothian Patient Group Direction Version: 006

z_4-/01/11 ,c.,u V clf..rm-t PGD for the administration of Phytomenadione (Konakion MM Paediatric 2mg/0.2ml solution for injection) via the oral route

Clinical Condition Indication:

PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017

Care Homes - Homely Remedies Protocol

patient group direction

Patient Group Direction for SALBUTAMOL INHALER (Version 02) Valid From 1 October September 2019

Patient Group Direction For the supply and administration of

Care homes - Homely remedies

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices

patient group direction

PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF ORAL DIAZEPAM TO WORKING AGE AND OLDER PEOPLE IN THE COMMUNITY

THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:

for adults engaged with the Family Wellbeing Service Isle of Wight In Community Pharmacy for Isle of Wight Public Health Commissioned Services

Patient Group Direction for GLUCAGON (Version 02) Valid From 1 October September 2019

Patient Group Direction (PGD) Supply of Nitrofurantoin for uncomplicated Urinary Tract Infections in females aged 16 years and over

GG&C PGD ref no: 2016/1309 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

Job Title Name Signature Date. Director of Nursing Angela Wallace Signed Angela Wallace 30/6/2014

Patient Group Direction

CLINICAL CONTENT OF PATIENT GROUP DIRECTION FOR ACUTE OTITIS MEDIA. AMOXICILLIN

Patient Group Direction for Doxycycline (Tetracycline) Version: 01 Start Date: October 2015 Expiry Date: October 2018

PGD for the administration of: Intradermal injections of Sterile Water for pain relief

patient group direction

Patient Group Direction (PGD) Number :

Patient Group Direction Hepatitis A vaccine Version: Hepatitis A 2015 Start Date: 1 st July 2015 Expiry Date:30 th June 2018

Patient Group Direction for the Supply of Trimethoprim 200mg tablets

PGD Version No.: 3/

Patient Group Direction for LIDOCAINE INJECTION (Version 02) Valid From 1 October September 2019

patient group direction

National Patient Group Direction for the Supply of Azithromycin, by Pharmacists, for the Treatment of Uncomplicated Chlamydia Infection

Patient Group Direction (PGD)

CLINICAL CONTENT OF PATIENT GROUP DIRECTION FOR TREATMENT OF ACUTE OTITIS MEDIA. CLARITHROMYCIN

SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

PGD5717. Director of Quality & Clinical Performance. Therèsa Moyes

CLINICAL CONTENT OF PATIENT GROUP DIRECTION FOR PNEUMOCOCCAL CONJUGATE VACCINE (Prevenar 13 )

Care homes - Homely remedies

Consultation Group: See relevant page in the PGD. Review Date: October 2017

Version Number: 5. Patient Group Direction drawn up by: Chief Pharmacist - Strategy. Group direction authorised by:

GG&C PGD ref no: 2018/1601 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

Patient Group Directions (PGDs)

Patient Group Direction For The Administration Of H1N1 (Swine Flu) vaccine

NATIONAL PATIENT GROUP DIRECTION FOR SUPPLY OF PARACETAMOL ORAL SUSPENSION

GROUP PROTOCOL FOR THE MANAGEMENT OF SYMPTOMS OF COUGHS. Version 5 December 2017

CONJUGATE MENINGOCOCCAL (ACWY) VACCINE

Title Protocol for Insect Bites Stings for Patients in MIUs and WICs

patient group direction

Patient Group Direction for Rotavirus vaccine Version: ROTAVIRUS (Rotarix ) Start Date: 1 st July 2013 Expiry Date:30 th June 2015

Patient Group Direction (PGD) Number :

Transcription:

Patient Group Direction for the supply and/or administration of Paracetamol Oral Suspension 250mg/5ml (Paracetamol paediatric suspension) to children receiving treatment from NHS Borders services. This document authorises the supply and/or administration of Paracetamol oral suspension 250mg/5ml (Paracetamol paediatric suspension) by registered nurses to patients who meet the criteria for inclusion under the terms of the document The registered nurse seeking to supply and/or administer Paracetamol oral suspension 250mg/5ml (Paracetamol paediatric suspension) must ensure that all clients have been screened and meet the criteria before supply takes place The purpose of this Patient Group Direction is to help patients by providing them with more convenient access to pain relief in an efficient manner in the absence of medical cover. PGD previously approved: 01/11/2004 This direction was authorised on: March 2011 The direction will be reviewed by: March 2013 Clinician Responsible for Training and Review: Emergency Department Consultant PGD Reviewed by: Jacques Kerr, Beverly Meins, Clare Ketteridge, Gavin Gorman PGD for the supply/admin of Paracetamol Suspension 250mg/5ml 1

Patient Group Direction for administration of Paracetamol oral suspension 250mg/5ml (Paracetamol paediatric suspension) without a prescription for a named individual by registered nurses employed by NHS Borders. 1. This Patient Group Direction relates to the following specific preparation: Name of medicine, strength, formulation Legal status Storage Dose Route/method Frequency Total dose Quantity (Maximum/Minimum) Advice to Patients Relevant Warnings Follow up Arrangements Paracetamol Suspension 250mg/5ml (Paracetamol paediatric suspension) General Sales List (GSL) Store below 25 C and protect from light. 6-12 years 250-500mg 12-18 years 500mg Select dose depending on age, size of child and severity of pain. Oral Suspension Dose can be repeated at 4-6 hour intervals up to a maximum of 4 doses in 24 hours. Maximum: 4 doses in 24 hours (Maximum permitted supply 5000mg in 100ml) Advise patient s parent/guardian of treatment given Ensure awareness of the maximum dose/frequency Advise against the use of other products containing Paracetamol Advise to contact a doctor if the symptoms don t improve or get worse Anaphylaxis refer immediately for medical attention and treat as per NHS Borders anaphylaxis protocol/pgd. Adverse effects are rare see BNF for full details. Observe for effectiveness of pain relief. Seek medical advice if fails to respond to treatment or condition deteriorates. PGD for the supply/admin of Paracetamol Suspension 250mg/5ml 2

2. Clinical condition Clinical Condition to be treated Criteria for inclusion Criteria for exclusion Action if excluded or declines Interactions with other medicaments and other forms of interaction Referral Patients who require mild to moderate pain relief. Patients presenting with mild to moderate pain Children over the age of 6 years Medical and drug history taken, with no reason for exclusion Pyrexia Children under 6 years of age. (Refer to Paracetamol 120mg/5ml PGD) Patients with a known allergy to Paracetamol Patients who have taken any product containing Paracetamol in the previous four hours. Patients who cannot swallow Patients who have pain known to be unresponsive to Paracetamol. Patients with severe hepatic dysfunction. The patient must be referred to a doctor. The reason for referral should be documented. Few interactions. See current BNF for full list and details. Patients may be referred to a prescribing practitioner at any stage. Patients should be referred if the treatment proves to be ineffective in relieving the symptoms. 3. Records: As per department protocol a) The following records should be kept (either paper or computer based) The GP practice, clinic, hospital, and ward or department The patient name and CHI number The medicine name, dose, route, time of dose(s), and where appropriate, start date, number of doses and or period of time, for which the medicine is to be supplied or administered Drug batch number and expiry The signature and printed name of the approved healthcare professional that supplied or administered the medicine The patient group direction title and/or number If patient met the inclusion criteria and if the exclusion criteria was assessed Quantity supplied / received and current stock balance b) Preparation, audit trail, data collection and reconciliation- Stock balances should be reconcilable with receipts, administration, records and disposals on a patient by patient basis. PGD for the supply/admin of Paracetamol Suspension 250mg/5ml 3

c) Storage-Store below 25 C and protect from light. Standards must be consistent with the Summary of Product Characteristics. 4. Professional Responsibility All Health Professionals will ensure they have the relevant training and are competent in all aspects of medication use, including contraindications and the recognition and treatment of adverse effects. He/she will attend training updates as appropriate. For those involved in immunization, regular anaphylaxis updates are mandatory. Nurses will have due regard for the NMC Code of Professional Conduct, standards for conduct, performance and ethics (2008) and NMC Standards for Medicines Management (2007) 5. References British National Formulary (BNF) current edition http://bnf.org/bnf/index.htm British National Formulary (BNF) Children edition http://bnfc.org/bnfc/bnfc/current/ Borders Joint Formulary (BJF) http://intranet/new_intranet/microsites/index.asp?siteid=65&uid=1 Paracetamol SPC www.medicines.org.uk PGD for the supply/admin of Paracetamol Suspension 250mg/5ml 4

PGD for the supply/admin of Paracetamol Suspension 250mg/5ml 5